Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
CONCLUSION: Both progestin-only contraceptives significantly reduced two out of the three biomarkers evaluated. These two biomarkers could, therefore, be used as surrogate markers to follow up medical treatment of endometriosis-associated pain.
PMID: 30372645 [PubMed - as supplied by publisher]
Source: The European Journal of Contraception and Reproductive Health Care - Category: Reproduction Medicine Authors: Margatho D, Mota Carvalho N, Eloy L, Bahamondes L Tags: Eur J Contracept Reprod Health Care Source Type: research
More News: Brazil Health | Cancer | Cancer & Oncology | Clinical Trials | Endometrial Cancer | Endometriosis | Fibre | Health Management | Mirena | MRI Scan | OBGYN | Pain | Reproduction Medicine | Study | Ultrasound | Women